N-[(1S)-3-[4-[(2S,3R)-3-[(2-cyclopropylacetyl)amino]-4-(4-methylpiperazin-1-yl)-4-oxobutan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-3-[(2-fluoro-2-methylpropanoyl)amino]-4-(4-methylpiperazin-1-yl)-4-oxobutan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-(4-methylpiperazin-1-yl)-3-(2-methylpropanoylamino)-4-oxobutan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;(3R)-4-[[(2R,3S)-3-[4-[(3S)-3-[(4-ethyl-1,2,5-oxadiazole-3-carbonyl)amino]-3-(4-methylcyclohexyl)-2-oxopropyl]-3-fluorophenyl]-1-(4-methylpiperazin-1-yl)-1-oxobutan-2-yl]amino]-3-methyl-4-oxobutanoic acid

C138H195F5N24O22 — CID 167548172

About N-[(1S)-3-[4-[(2S,3R)-3-[(2-cyclopropylacetyl)amino]-4-(4-methylpiperazin-1-yl)-4-oxobutan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-3-[(2-fluoro-2-methylpropanoyl)amino]-4-(4-methylpiperazin-1-yl)-4-oxobutan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-(4-methylpiperazin-1-yl)-3-(2-methylpropanoylamino)-4-oxobutan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;(3R)-4-[[(2R,3S)-3-[4-[(3S)-3-[(4-ethyl-1,2,5-oxadiazole-3-carbonyl)amino]-3-(4-methylcyclohexyl)-2-oxopropyl]-3-fluorophenyl]-1-(4-methylpiperazin-1-yl)-1-oxobutan-2-yl]amino]-3-methyl-4-oxobutanoic acid

N-[(1S)-3-[4-[(2S,3R)-3-[(2-cyclopropylacetyl)amino]-4-(4-methylpiperazin-1-yl)-4-oxobutan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-3-[(2-fluoro-2-methylpropanoyl)amino]-4-(4-methylpiperazin-1-yl)-4-oxobutan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-(4-methylpiperazin-1-yl)-3-(2-methylpropanoylamino)-4-oxobutan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;(3R)-4-[[(2R,3S)-3-[4-[(3S)-3-[(4-ethyl-1,2,5-oxadiazole-3-carbonyl)amino]-3-(4-methylcyclohexyl)-2-oxopropyl]-3-fluorophenyl]-1-(4-methylpiperazin-1-yl)-1-oxobutan-2-yl]amino]-3-methyl-4-oxobutanoic acid (PubChem CID 167548172) has the molecular formula C138H195F5N24O22 and a molecular weight of 2637.21 g/mol. Its IUPAC name is N-[(1S)-3-[4-[(2S,3R)-3-[(2-cyclopropylacetyl)amino]-4-(4-methylpiperazin-1-yl)-4-oxobutan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-3-[(2-fluoro-2-methylpropanoyl)amino]-4-(4-methylpiperazin-1-yl)-4-oxobutan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-(4-methylpiperazin-1-yl)-3-(2-methylpropanoylamino)-4-oxobutan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;(3R)-4-[[(2R,3S)-3-[4-[(3S)-3-[(4-ethyl-1,2,5-oxadiazole-3-carbonyl)amino]-3-(4-methylcyclohexyl)-2-oxopropyl]-3-fluorophenyl]-1-(4-methylpiperazin-1-yl)-1-oxobutan-2-yl]amino]-3-methyl-4-oxobutanoic acid.

Molecular Properties

• Compound Name: N-[(1S)-3-[4-[(2S,3R)-3-[(2-cyclopropylacetyl)amino]-4-(4-methylpiperazin-1-yl)-4-oxobutan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-3-[(2-fluoro-2-methylpropanoyl)amino]-4-(4-methylpiperazin-1-yl)-4-oxobutan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-(4-methylpiperazin-1-yl)-3-(2-methylpropanoylamino)-4-oxobutan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;(3R)-4-[[(2R,3S)-3-[4-[(3S)-3-[(4-ethyl-1,2,5-oxadiazole-3-carbonyl)amino]-3-(4-methylcyclohexyl)-2-oxopropyl]-3-fluorophenyl]-1-(4-methylpiperazin-1-yl)-1-oxobutan-2-yl]amino]-3-methyl-4-oxobutanoic acid
• PubChem CID: 167548172
• Molecular Formula: C138H195F5N24O22
• Molecular Weight: 2637.21 g/mol
• Exact Mass: 2635.48
• IUPAC Name: N-[(1S)-3-[4-[(2S,3R)-3-[(2-cyclopropylacetyl)amino]-4-(4-methylpiperazin-1-yl)-4-oxobutan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-3-[(2-fluoro-2-methylpropanoyl)amino]-4-(4-methylpiperazin-1-yl)-4-oxobutan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-(4-methylpiperazin-1-yl)-3-(2-methylpropanoylamino)-4-oxobutan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;(3R)-4-[[(2R,3S)-3-[4-[(3S)-3-[(4-ethyl-1,2,5-oxadiazole-3-carbonyl)amino]-3-(4-methylcyclohexyl)-2-oxopropyl]-3-fluorophenyl]-1-(4-methylpiperazin-1-yl)-1-oxobutan-2-yl]amino]-3-methyl-4-oxobutanoic acid
• SMILES: CCc1nonc1C(=O)N[C@H](C(=O)Cc1ccc([C@H](C)[C@@H](NC(=O)C(C)(C)F)C(=O)N2CCN(C)CC2)cc1F)C1CCC(C)CC1.CCc1nonc1C(=O)N[C@H](C(=O)Cc1ccc([C@H](C)[C@@H](NC(=O)C(C)C)C(=O)N2CCN(C)CC2)cc1F)C1CCC(C)CC1.CCc1nonc1C(=O)N[C@H](C(=O)Cc1ccc([C@H](C)[C@@H](NC(=O)CC2CC2)C(=O)N2CCN(C)CC2)cc1F)C1CCC(C)CC1.CCc1nonc1C(=O)N[C@H](C(=O)Cc1ccc([C@H](C)[C@@H](NC(=O)[C@H](C)CC(=O)O)C(=O)N2CCN(C)CC2)cc1F)C1CCC(C)CC1
• InChI: InChI=1S/C35H49FN6O7.C35H49FN6O5.C34H48F2N6O5.C34H49FN6O5/c1-6-27-32(40-49-39-27)34(47)38-31(23-9-7-20(2)8-10-23)28(43)19-25-12-11-24(18-26(25)36)22(4)30(37-33(46)21(3)17-29(44)45)35(48)42-15-13-41(5)14-16-42;1-5-28-33(40-47-39-28)34(45)38-32(24-10-6-21(2)7-11-24)29(43)20-26-13-12-25(19-27(26)36)22(3)31(37-30(44)18-23-8-9-23)35(46)42-16-14-41(4)15-17-42;1-7-26-30(40-47-39-26)31(44)37-29(22-10-8-20(2)9-11-22)27(43)19-24-13-12-23(18-25(24)35)21(3)28(38-33(46)34(4,5)36)32(45)42-16-14-41(6)15-17-42;1-7-27-31(39-46-38-27)33(44)37-30(23-10-8-21(4)9-11-23)28(42)19-25-13-12-24(18-26(25)35)22(5)29(36-32(43)20(2)3)34(45)41-16-14-40(6)15-17-41/h11-12,18,20-23,30-31H,6-10,13-17,19H2,1-5H3,(H,37,46)(H,38,47)(H,44,45);12-13,19,21-24,31-32H,5-11,14-18,20H2,1-4H3,(H,37,44)(H,38,45);12-13,18,20-22,28-29H,7-11,14-17,19H2,1-6H3,(H,37,44)(H,38,46);12-13,18,20-23,29-30H,7-11,14-17,19H2,1-6H3,(H,36,43)(H,37,44)/t20?,21-,22+,23?,30-,31+;21?,22-,24?,31+,32-;20?,21-,22?,28+,29-;21?,22-,23?,29+,30-/m1000/s1
• InChIKey: CBHPJJXNIGDIMS-WLFSVLBCSA-N
• XLogP: 13.79
• TPSA: 588.26 Ų
• H-Bond Donors: 9
• H-Bond Acceptors: 33
• Rotatable Bonds: 51
• Heavy Atoms: 189
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2637.21
LogP ≤ 5	13.79
H-Bond Donors ≤ 5	9
H-Bond Acceptors ≤ 10	33

Frequently Asked Questions

What is the IUPAC name of N-[(1S)-3-[4-[(2S,3R)-3-[(2-cyclopropylacetyl)amino]-4-(4-methylpiperazin-1-yl)-4-oxobutan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-3-[(2-fluoro-2-methylpropanoyl)amino]-4-(4-methylpiperazin-1-yl)-4-oxobutan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-(4-methylpiperazin-1-yl)-3-(2-methylpropanoylamino)-4-oxobutan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;(3R)-4-[[(2R,3S)-3-[4-[(3S)-3-[(4-ethyl-1,2,5-oxadiazole-3-carbonyl)amino]-3-(4-methylcyclohexyl)-2-oxopropyl]-3-fluorophenyl]-1-(4-methylpiperazin-1-yl)-1-oxobutan-2-yl]amino]-3-methyl-4-oxobutanoic acid?

The IUPAC name of N-[(1S)-3-[4-[(2S,3R)-3-[(2-cyclopropylacetyl)amino]-4-(4-methylpiperazin-1-yl)-4-oxobutan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-3-[(2-fluoro-2-methylpropanoyl)amino]-4-(4-methylpiperazin-1-yl)-4-oxobutan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-(4-methylpiperazin-1-yl)-3-(2-methylpropanoylamino)-4-oxobutan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;(3R)-4-[[(2R,3S)-3-[4-[(3S)-3-[(4-ethyl-1,2,5-oxadiazole-3-carbonyl)amino]-3-(4-methylcyclohexyl)-2-oxopropyl]-3-fluorophenyl]-1-(4-methylpiperazin-1-yl)-1-oxobutan-2-yl]amino]-3-methyl-4-oxobutanoic acid (CID 167548172) is N-[(1S)-3-[4-[(2S,3R)-3-[(2-cyclopropylacetyl)amino]-4-(4-methylpiperazin-1-yl)-4-oxobutan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-3-[(2-fluoro-2-methylpropanoyl)amino]-4-(4-methylpiperazin-1-yl)-4-oxobutan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-(4-methylpiperazin-1-yl)-3-(2-methylpropanoylamino)-4-oxobutan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;(3R)-4-[[(2R,3S)-3-[4-[(3S)-3-[(4-ethyl-1,2,5-oxadiazole-3-carbonyl)amino]-3-(4-methylcyclohexyl)-2-oxopropyl]-3-fluorophenyl]-1-(4-methylpiperazin-1-yl)-1-oxobutan-2-yl]amino]-3-methyl-4-oxobutanoic acid.

What is the SMILES notation for N-[(1S)-3-[4-[(2S,3R)-3-[(2-cyclopropylacetyl)amino]-4-(4-methylpiperazin-1-yl)-4-oxobutan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-3-[(2-fluoro-2-methylpropanoyl)amino]-4-(4-methylpiperazin-1-yl)-4-oxobutan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-(4-methylpiperazin-1-yl)-3-(2-methylpropanoylamino)-4-oxobutan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;(3R)-4-[[(2R,3S)-3-[4-[(3S)-3-[(4-ethyl-1,2,5-oxadiazole-3-carbonyl)amino]-3-(4-methylcyclohexyl)-2-oxopropyl]-3-fluorophenyl]-1-(4-methylpiperazin-1-yl)-1-oxobutan-2-yl]amino]-3-methyl-4-oxobutanoic acid?

The canonical SMILES for N-[(1S)-3-[4-[(2S,3R)-3-[(2-cyclopropylacetyl)amino]-4-(4-methylpiperazin-1-yl)-4-oxobutan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-3-[(2-fluoro-2-methylpropanoyl)amino]-4-(4-methylpiperazin-1-yl)-4-oxobutan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-(4-methylpiperazin-1-yl)-3-(2-methylpropanoylamino)-4-oxobutan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;(3R)-4-[[(2R,3S)-3-[4-[(3S)-3-[(4-ethyl-1,2,5-oxadiazole-3-carbonyl)amino]-3-(4-methylcyclohexyl)-2-oxopropyl]-3-fluorophenyl]-1-(4-methylpiperazin-1-yl)-1-oxobutan-2-yl]amino]-3-methyl-4-oxobutanoic acid is CCc1nonc1C(=O)N[C@H](C(=O)Cc1ccc([C@H](C)[C@@H](NC(=O)C(C)(C)F)C(=O)N2CCN(C)CC2)cc1F)C1CCC(C)CC1.CCc1nonc1C(=O)N[C@H](C(=O)Cc1ccc([C@H](C)[C@@H](NC(=O)C(C)C)C(=O)N2CCN(C)CC2)cc1F)C1CCC(C)CC1.CCc1nonc1C(=O)N[C@H](C(=O)Cc1ccc([C@H](C)[C@@H](NC(=O)CC2CC2)C(=O)N2CCN(C)CC2)cc1F)C1CCC(C)CC1.CCc1nonc1C(=O)N[C@H](C(=O)Cc1ccc([C@H](C)[C@@H](NC(=O)[C@H](C)CC(=O)O)C(=O)N2CCN(C)CC2)cc1F)C1CCC(C)CC1.

What is the InChIKey of N-[(1S)-3-[4-[(2S,3R)-3-[(2-cyclopropylacetyl)amino]-4-(4-methylpiperazin-1-yl)-4-oxobutan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-3-[(2-fluoro-2-methylpropanoyl)amino]-4-(4-methylpiperazin-1-yl)-4-oxobutan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-(4-methylpiperazin-1-yl)-3-(2-methylpropanoylamino)-4-oxobutan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;(3R)-4-[[(2R,3S)-3-[4-[(3S)-3-[(4-ethyl-1,2,5-oxadiazole-3-carbonyl)amino]-3-(4-methylcyclohexyl)-2-oxopropyl]-3-fluorophenyl]-1-(4-methylpiperazin-1-yl)-1-oxobutan-2-yl]amino]-3-methyl-4-oxobutanoic acid?

The InChIKey is CBHPJJXNIGDIMS-WLFSVLBCSA-N. The full InChI is InChI=1S/C35H49FN6O7.C35H49FN6O5.C34H48F2N6O5.C34H49FN6O5/c1-6-27-32(40-49-39-27)34(47)38-31(23-9-7-20(2)8-10-23)28(43)19-25-12-11-24(18-26(25)36)22(4)30(37-33(46)21(3)17-29(44)45)35(48)42-15-13-41(5)14-16-42;1-5-28-33(40-47-39-28)34(45)38-32(24-10-6-21(2)7-11-24)29(43)20-26-13-12-25(19-27(26)36)22(3)31(37-30(44)18-23-8-9-23)35(46)42-16-14-41(4)15-17-42;1-7-26-30(40-47-39-26)31(44)37-29(22-10-8-20(2)9-11-22)27(43)19-24-13-12-23(18-25(24)35)21(3)28(38-33(46)34(4,5)36)32(45)42-16-14-41(6)15-17-42;1-7-27-31(39-46-38-27)33(44)37-30(23-10-8-21(4)9-11-23)28(42)19-25-13-12-24(18-26(25)35)22(5)29(36-32(43)20(2)3)34(45)41-16-14-40(6)15-17-41/h11-12,18,20-23,30-31H,6-10,13-17,19H2,1-5H3,(H,37,46)(H,38,47)(H,44,45);12-13,19,21-24,31-32H,5-11,14-18,20H2,1-4H3,(H,37,44)(H,38,45);12-13,18,20-22,28-29H,7-11,14-17,19H2,1-6H3,(H,37,44)(H,38,46);12-13,18,20-23,29-30H,7-11,14-17,19H2,1-6H3,(H,36,43)(H,37,44)/t20?,21-,22+,23?,30-,31+;21?,22-,24?,31+,32-;20?,21-,22?,28+,29-;21?,22-,23?,29+,30-/m1000/s1.

What are the key properties of N-[(1S)-3-[4-[(2S,3R)-3-[(2-cyclopropylacetyl)amino]-4-(4-methylpiperazin-1-yl)-4-oxobutan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-3-[(2-fluoro-2-methylpropanoyl)amino]-4-(4-methylpiperazin-1-yl)-4-oxobutan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-(4-methylpiperazin-1-yl)-3-(2-methylpropanoylamino)-4-oxobutan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;(3R)-4-[[(2R,3S)-3-[4-[(3S)-3-[(4-ethyl-1,2,5-oxadiazole-3-carbonyl)amino]-3-(4-methylcyclohexyl)-2-oxopropyl]-3-fluorophenyl]-1-(4-methylpiperazin-1-yl)-1-oxobutan-2-yl]amino]-3-methyl-4-oxobutanoic acid?

N-[(1S)-3-[4-[(2S,3R)-3-[(2-cyclopropylacetyl)amino]-4-(4-methylpiperazin-1-yl)-4-oxobutan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-3-[(2-fluoro-2-methylpropanoyl)amino]-4-(4-methylpiperazin-1-yl)-4-oxobutan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-(4-methylpiperazin-1-yl)-3-(2-methylpropanoylamino)-4-oxobutan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;(3R)-4-[[(2R,3S)-3-[4-[(3S)-3-[(4-ethyl-1,2,5-oxadiazole-3-carbonyl)amino]-3-(4-methylcyclohexyl)-2-oxopropyl]-3-fluorophenyl]-1-(4-methylpiperazin-1-yl)-1-oxobutan-2-yl]amino]-3-methyl-4-oxobutanoic acid has a molecular weight of 2637.21 g/mol, XLogP of 13.79, 51 rotatable bonds, 9 hydrogen bond donors, and 33 hydrogen bond acceptors.

Where does this data come from?

All data for N-[(1S)-3-[4-[(2S,3R)-3-[(2-cyclopropylacetyl)amino]-4-(4-methylpiperazin-1-yl)-4-oxobutan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-4-ethyl-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-3-[(2-fluoro-2-methylpropanoyl)amino]-4-(4-methylpiperazin-1-yl)-4-oxobutan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;4-ethyl-N-[(1S)-3-[2-fluoro-4-[(2S,3R)-4-(4-methylpiperazin-1-yl)-3-(2-methylpropanoylamino)-4-oxobutan-2-yl]phenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-1,2,5-oxadiazole-3-carboxamide;(3R)-4-[[(2R,3S)-3-[4-[(3S)-3-[(4-ethyl-1,2,5-oxadiazole-3-carbonyl)amino]-3-(4-methylcyclohexyl)-2-oxopropyl]-3-fluorophenyl]-1-(4-methylpiperazin-1-yl)-1-oxobutan-2-yl]amino]-3-methyl-4-oxobutanoic acid is sourced from PubChem (CID 167548172), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).